[1] CHIMOWITZ M I，LYNN M J，HOWLETT-SMITH

H，et al. Comparison of warfarin and aspirin for

symptomatic intracranial arterial stenosis[J]. N Engl

J Med，2005，352（13）：1305-1316.

[2] SACCO R L，KARGMAN D E，GU Q，et al.

Race-ethnicity and determinants of intracranial

atherosclerotic cerebral infarction. The Northern

Manhattan Stroke Study[J]. Stroke，1995，26（1）：

14-20.

[3] WONG K S，HUANG Y N，GAO S，et al.

Intracranial stenosis in Chinese patients with acute

stroke[J]. Neurology，1998，50（3）：812-813.

[4] BERKHEMER O A，FRANSEN P S，BEUMER D，

et al. A randomized trial of intraarterial treatment

for acute ischemic stroke[J]. N Engl J Med，2015，372

（1）：11-20.

[5] CAMPBELL B C，MITCHELL P J，KLEINIG T J，

et al. Endovascular therapy for ischemic stroke with

perfusion-imaging selection[J]. N Engl J Med，2015，

372（11）：1009-1018.

[6] GOYAL M，DEMCHUK A M，MENON B K，et

al. Randomized assessment of rapid endovascular

treatment of ischemic stroke[J]. N Engl J Med，2015，

372（11）：1019-1030.

[7] JOVIN T G，CHAMORRO A，COBO E，et al.

Thrombectomy within 8 hours after symptom onset

in ischemic stroke[J]. N Engl J Med，2015，372（24）：

2296-2306.

[8] SAVER J L，GOYAL M，BONAFE A，et al. Stentretriever

thrombectomy after intravenous t-PA vs.

t-PA alone in stroke[J]. N Engl J Med，2015，372

（24）：2285-2295.

[9] NOGUEIRA R G，JADHAV A P，HAUSSEN D C，

et al. Thrombectomy 6 to 24 Hours after Stroke with

a Mismatch between Deficit and Infarct[J]. N Engl J

Med，2018，378（1）：11-21.

[10] ALBERS G W，MARKS M P，KEMP S，et al.

Thrombectomy for Stroke at 6 to 16 Hours with

Selection by Perfusion Imaging[J]. N Engl J Med，2018，378（8）：708-718.

[11] GORELICK P B. Distribution of atherosclerotic

cerebrovascular lesions. Effects of age，race，and

sex[J]. Stroke，1993，24（12 Suppl）：116-121.

[12] WONG L K. Global burden of intracranial

atherosclerosis[J]. Int J Stroke，2006，1（3）：158-159.

[13] A MATTIONI A，CENCIARELLI S，BIESSELS G，

et al. Prevalence of intracranial large artery stenosis

and occlusion in patients with acute ischaemic stroke

or TIA[J]. Neurol Sci，2014，35（3）：349-355.

[14] GORELICK P B，WONG K S，BAE H J，et al.

Large artery intracranial occlusive disease：a

large worldwide burden but a relatively neglected

frontier[J]. Stroke，2008，39（8）：2396-2399.

[15] WANG Y，ZHAO X，LIU L，et al. Prevalence and

outcomes of symptomatic intracranial large artery

stenoses and occlusions in China：the Chinese

Intracranial Atherosclerosis（CICAS）Study[J].

Stroke，2014，45（3）：663-669.

[16] MARSHALL R S，FESTA J R，CHEUNG Y

K，et al. Cerebral hemodynamics and cognitive

impairment：baseline data from the RECON trial[J].

Neurology，2012，78（4）：250-255.

[17] J KHATRI J，ABDALLAH M，ELLIS S.

Management of coronary chronic total occlusion[J].

Cleve Clin J Med，2017，84（12 Suppl 3）：27-38.

[18] XU B，LI C，GUO Y，et al. Current understanding

of chronic total occlusion of the internal carotid

artery[J]. Biomed Rep，2018，8（2）：117-125.

[19] WEIMAR C，GOERTLER M，HARMS L，et al.

Distribution and outcome of symptomatic stenoses

and occlusions in patients with acute cerebral

ischemia[J]. Arch Neurol，2006，63（9）：1287-1291.

[20] HERNANDEZ-PÉREZ M，PÉREZ DE LA OSSA

N，ALEU A，et al. Natural History of Acute Stroke

due to Occlusion of the Middle Cerebral Artery

and Intracranial Internal Carotid Artery[J]. J

Neuroimaging，2014，24（4）：354-358.

[21] ROTZINGER D C，MOSIMANN P J，MEULI

R A，et al. Site and Rate of Occlusive Disease in

Cervicocerebral Arteries：A CT Angiography Study

of 2209 Patients with Acute Ischemic Stroke[J].

AJNR Am J Neuroradiol，2017，38（5）：868-874.

[22] HAN J H，HO S S，LAM W W，et al. Total cerebral

blood flow estimated by color velocity imaging

quantification ultrasound：a predictor for recurrent

stroke?[J]. J Cereb Blood Flow Metab，2007，27（4）：

850-856.

[23] WONG K S，GAO S，CHAN Y L，et al. Mechanisms

of acute cerebral infarctions in patients with middle

cerebral artery stenosis：a perfusion-weighted

imaging and microemboli monitoring study[J]. Ann

Neurol，2002，52（1）：74-81.

[24] KURODA S，HOUKIN K，KAMIYAMA H，et al.

Long-term prognosis of medically treated patients

with internal carotid or middle cerebral artery

occlusion：can acetazolamide test predict it?[J].

Stroke，2001，32（9）：2110-2116.

[25] AMIN-HANJANI S，DU X，ZHAO M，et al. Use

of quantitative magnetic resonance angiography to

stratify stroke risk in symptomatic vertebrobasilar

disease[J]. Stroke，2005，36（6）：1140-1145.

[26] AMIN-HANJANI S，PANDEY D K，ROSEFINNELL

L，et al. Effect of Hemodynamics

on Stroke Risk in Symptomatic Atherosclerotic

Vertebrobasilar Occlusive Disease[J]. JAMA Neurol，

2016，73（2）：178-185.

[27] BRACARD S，DUCROCQ X，MAS J L，et

al. Mechanical thrombectomy after intravenous

alteplase versus alteplase alone after stroke

（THRACE）：a randomised controlled trial[J].

Lancet Neurol，2016，15（11）：1138-1147.

[28] 霍晓川，高峰，缪中荣，等. 急性缺血性卒中血管内

治疗中国指南2018[J]. 中国卒中杂志，2018，13（7）：

726-729.

[29] ZHU G，MICHEL P，AGHAEBRAHIM A，et al.

Computed tomography workup of patients suspected

of acute ischemic stroke：perfusion computed

tomography adds value compared with clinical

evaluation，noncontrast computed tomography，

and computed tomography angiogram in terms of

predicting outcome[J]. Stroke，2013，44（4）：1049-

1055.

[30] ZHU G，MICHEL P，AGHAEBRAHIM A，et al.

Prediction of recanalization trumps prediction of

tissue fate：the penumbra：a dual-edged sword[J].

Stroke，2013，44（4）：1014-1019.

[31] BERKHEMER O A，JANSENIG I G，BEUMER

D，et al. Collateral Status on Baseline Computed

Tomographic Angiography and Intra-Arterial

Treatment Effect in Patients With Proximal Anterior

Circulation Stroke[J]. Stroke，2016，47（3）：768-776.

[32] MENONB K，QAZI E，NAMBIAR V，et

al. Differential Effect of Baseline Computed

Tomographic Angiography Collaterals on Clinical

Outcome in Patients Enrolled in the Interventional

Management of Stroke III Trial[J]. Stroke，2015，46

（5）：1239-1244.

[33] YUAN H W，JI R J，WANG A L，et al. A Grading

Scale for Pial Collaterals in Middle Cerebral

Artery Total Occlusion Based on Time-of-flight MR

Angiography Source Images[J/OL]. Magn Reson Med Sci. 2018 May 31. https：//doi.org/10.2463/

mrms.mp.2018-0001.

[34] LIANG J，GUO J，LIU D，et al. Application of

High-Resolution CUBE Sequence in Exploring

Stroke Mechanisms of Atherosclerotic Stenosis of

Middle Cerebral Artery[J/OL]. J Stroke Cerebrovasc

Dis，2018，pii：S1052-3057（18）30524-X. https：//

doi.org/10.1016/j.jstrokecerebrovasdis.2018.09.021.

[35] ZHANG D F，CHEN Y C，CHEN H，et al. A High-

Resolution MRI Study of Relationship between

Remodeling Patterns and Ischemic Stroke in Patients

with Atherosclerotic Middle Cerebral Artery

Stenosis[J/OL]. Front Aging Neurosci，2017，9：140.

https：//doi.org/10.3389/fnagi.2017.00140

[36] MORINO Y，ABE M，MORIMOTO T，et al.

Predicting successful guidewire crossing through

chronic total occlusion of native coronary lesions

within 30 minutes：the J-CTO（Multicenter CTO

Registry in Japan）score as a difficulty grading and

time assessment tool[J]. JACC Cardiovasc Interv，

2011，4（2）：213-221.

[37] CHEN Y H，LEONG W S，LIN M S，et al.

Predictors for Successful Endovascular Intervention

in Chronic Carotid Artery Total Occlusion[J]. JACC

Cardiovasc Interv，2016，9（17）：1825-1832.

[38] WONG K S，CHEN C，NG P W，et al. Lowmolecular-

weight heparin compared with aspirin

for the treatment of acute ischaemic stroke in Asian

patients with large artery occlusive disease：a

randomised study[J]. Lancet Neurol，2007，6（5）：

407-413.

[39] WANG Q，CHEN C，CHEN X Y，et al. Low-

Molecular-Weight Heparin and Early Neurologic

Deterioration in Acute Stroke Caused by Large

Artery Occlusive Disease[J]. Arch Neurol，2012，69

（11）：1454-1460.

[40] YU D D，PU Y H，PAN Y S，et al. High Blood

Pressure Increases the Risk of Poor Outcome at

Discharge and 12-month Follow-up in Patients with

Symptomatic Intracranial Large Artery Stenosis

and Occlusions：Subgroup analysis of the CICAS

Study[J]. CNS Neurosci Ther，2015，21（6）：530-

535.

[41] CHIMOWITZ M I，LYNN M J，DERDEYN C P，et

al. Stenting versus Aggressive Medical Therapy for

Intracranial Arterial Stenosis[J]. N Engl J Med，2011，

365（11）：993-1003.

[42] ZHANG C，ZHAO S，ZANG Y，et al. The

efficacy and safety of Dl-3n-butylphthalide on

progressive cerebral infarction：A randomized

controlled STROBE study[J/OL]. Medicine，

2017，96（30）：e7257. https：//doi.org/10.1097/

MD.0000000000007257.

[43] POWERS W J，CLARKE W R，GRUBB RL J R，

et al. Extracranial-intracranial bypass surgery for

stroke prevention in hemodynamic cerebral ischemia：

the Carotid Occlusion Surgery Study randomized

trial[J]. JAMA，2011，306（18）：1983-1992.

[44] CHOU C W，CHANG J H，LIN S Z，et al.

Extracranial - intracranial（EC - IC）bypass of

symptomatic middle cerebral artery（MCA）total

occlusion for haemodynamic impairment patients[J].

Br J Neurosurg，2012，26（6）：823-826.

[45] LEE S B，HUH P W，KIM D S，et al. Early

superficial temporal artery to middle cerebral artery

bypass in acute ischemic stroke[J]. Clin Neurol

Neurosurg，2013，115（8）：1238-1244.

[46] LOW S W，TEO K，LWIN S，et al. Improvement

in cerebral hemodynamic parameters and outcomes

after superficial temporal artery-middle cerebral

artery bypass in patients with severe stenoocclusive

disease of the intracranial internal carotid or middle

cerebral arteries[J]. J Neurosurg，2015，123（3）：

662-669.

[47] KOMOTAR R J，STARKE R M，OTTEN M L，et

al. The role of indirect extracranial-intracranial

bypass in the treatment of symptomatic intracranial

atheroocclusive disease[J]. J Neurosurg，2009，110

（5）：896-904.

[48] RADOVNICKY T，VACHATA P，BARTOS R，et

al. The masaryk hospital extracranial-intracranial

bypass study[J]. Neurosurg Rev，2017，40（1）：53-

57.

[49] OGASAWARA K，OGAWA A. JET study（Japanese

EC-IC Bypass Trial）[J]. Nihon Rinsho，2006，64

（suppl 7）：524-527.

[50] INOUE A，KOHNO K，IWATA S，et al. Efficacy of

Early Superficial Temporal Artery-Middle Cerebral

Artery Double Anastomoses for Atherosclerotic

Occlusion in Patients with Progressing Stroke[J]. J

Stroke Cerebrovasc Dis，2017，26（4）：741-748.

[51] BURKHARDT J K，WINKLHOFER S，FIERSTRA

J，et al. Emergency Extracranial-Intracranial Bypass

to Revascularize Salvageable Brain Tissue in Acute

Ischemic Stroke Patients[J/OL]. World Neurosurg，

2018，109：e476-e485. https：//doi.org/10.1016/

j.wneu.2017.10.005.

[52] RICE C J，CHO S M，TAQUI A，et al. Early versus

Delayed Extracranial-Intracranial Bypass Surgery

in Symptomatic Atherosclerotic Occlusion[J/OL].

Neurosurgery，2018. https：//doi.org/10.1093/neuros/

nyy411.

[53] SCHMIEDEK P，OLTEANU-NERBE V，

MARGUTH F. Timing of extracranial-intracranial

arterial bypass surgery with special reference to

acute cerebral ischaemia. Neurosurg Rev，1983，6

（1）：19-24.

[54] TEO KAC，YEO T T，SHARMA V K. Long-term

outcome in extracranial-intracranial bypass surgery

for severe steno-occlusive disease of intracranial

internal carotid or middle cerebral artery[J/OL]. Clin

Neurol Neurosurg，2018，169：149-153. https：//doi.

org/10.1016/j.clineuro.2018.04.003

[55] JADHAV A，PANCZYKOWSKI D，JUMAA M，

et al. Angioplasty and stenting for symptomatic

extracranial non-tandem internal carotid artery

occlusion[J/OL]. J NeuroIntervent Surg，2018，pii：

neurintsurg-2018-013810. https：//doi.org/10.1136/

neurintsurg-2018-013810.

[56] THOMAS A J，GUPTA R，TAYAL A H，et

al. Stenting and angioplasty of the symptomatic

chronically occluded carotid artery[J]. AJNR Am J

Neuroradiol，2007，28（1）：168-171.

[57] TERADA T，YAMAGA H，TSUMOTO T，et al. Use

of an embolic protection system during endovascular

recanalization of a totally occluded cervical internal

carotid artery at thechronic stage. Case report[J]. J

Neurosurg，2005，102（3）：558-564.

[58] LIN M S，LIN L C，LI H Y，et al. Procedural safety

and potential vascular complicationof endovascular

recanalization for chronic cervical internal carotid

artery occlusion[J]. Circ Cardiovasc Interv，2008，1

（2）：119-125.

[59] SHOJIMA M，NEMOTO S，MORITA A，et al.

Protected endovascular revascularization of subacute

and chronic total occlusion of the internal carotid

artery[J]. AJNR Am J Neuroradiol，2010，31（3）：

481-486.

[60] MORI T，MORI K，FUKUOKA M，et al.

Percutaneous transluminal angioplasty for

total occlusion of middle cerebral arteries[J].

Neuroradiology，1997，39（1）：71-74.

[61] KOLE M，AMIN B，MARIN H，et al. Intracranial

angioplasty and stent placement for direct cerebral

revascularization of nonacute intracranial occlusions

and near occlusions[J/OL]. Neurosurg Focus，

2009，26（3）：E3. https：//doi.org/10.3171/2008.12.

FOCUS08269.

[62] LIN R，ALEU A，JANKOWITZ B，et al.

Endovascular revascularization of chronic

symptomatic vertebrobasilar occlusion[J]. J

Neuroimaging，2012，22（1）：74-79.

[63] YU W，KONSTANIAN V，FISHER M.

Endovascular recanalization of basilar occlusion 80

days after symptom onset[J]. Stroke，2007，38（4）：

1387-1389.

[64] MA N，MO D P，GAO F，et al. Endovascular

recanalization for chronic symptomatic

middle cerebral artery total occlusion[J/OL]. J

NeuroIntervent Surg，2013，5（3）：e15. https：//doi.

org/10.1136/neurintsurg-2012-010304.

[65] AGHAEBRAHIM A，JOVIN T，JADHAV A P，et

al. Endovascular recanalization of complete subacute

to chronic atherosclerotic occlusions of intracranial

arteries[J]. J NeuroIntervent Surg，2014，6（9）：

645-648.

[66] WAN Y，LO W T，LIU Y X，et al. Endovascular

revascularization of symptomatic chronic middle

cerebral artery occlusions：Two case reports[J].

Interventional Neuroradiology，2016，22（1）：84-87.

[67] HE X，ZHANG L，YANG J，et al. Multimodal

Therapy for Non-Superacute Vertebral Basilar Artery

Occlusion[J]. Intervent Neurol，2017，6（3-4）：254-

262.

[68] GAO P，WANG Y，MA Y，et al. Endovascular

recanalization for chronic symptomatic intracranial

vertebral artery total occlusion：Experience

of a single center and review of literature[J]. J

Neuroradiol，2018，45（5）：295-304.

[69] CHEN K，HOU X，ZHOU Z，et al. The efficacy and

safety of endovascular recanalization of occluded

large cerebral arteries during the subacute phase of

cerebral infarction：a case series report[J]. Stroke

Vasc Neurol，2017，2（3）：124-131.

[70] ZHANG J，ZHANG X，ZHANG J P，et al.

Endovascular recanalisation with drug coated

balloonfor chronic symptomatic middle cerebral

artery total occlusion[J/OL]. J Neurointerv

Surg，2018，10（9）：e24. https：//doi.org/10.1136/

neurintsurg-2017-013693.rep.